Splenic and immune alterations of the Sparc-null mouse accompany a lack of immune response

[1]  R. Weissleder,et al.  SPARC is a VCAM‐1 counter‐ligand that mediates leukocyte transmigration , 2007, Journal of leukocyte biology.

[2]  D. Ginzinger,et al.  Differential zonal expression and adrenocorticotropin regulation of secreted protein acidic and rich in cysteine (SPARC), a matricellular protein, in the midgestation human fetal adrenal gland: implications for adrenal development. , 2006, The Journal of clinical endocrinology and metabolism.

[3]  S. Goerdt,et al.  Stabilin-1, a homeostatic scavenger receptor with multiple functions , 2006, Journal of cellular and molecular medicine.

[4]  S. Goerdt,et al.  Novel Function of Alternatively Activated Macrophages: Stabilin-1-Mediated Clearance of SPARC1 , 2006, The Journal of Immunology.

[5]  N. Said,et al.  Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis. , 2005, The American journal of pathology.

[6]  G. Weitzer,et al.  Parietal endoderm secreted SPARC promotes early cardiomyogenesis in vitro. , 2005, Experimental cell research.

[7]  M. Colombo,et al.  Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice , 2005, Journal of Cell Science.

[8]  Mariano J. Alvarez,et al.  Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity. , 2005, Cancer research.

[9]  Qiwei Yang,et al.  Neuroblastoma Angiogenesis Is Inhibited with a Folded Synthetic Molecule Corresponding to the Epidermal Growth Factor-Like Module of the Follistatin Domain of SPARC , 2004, Cancer Research.

[10]  L. Staudt,et al.  Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs , 2004, BMC Immunology.

[11]  E. Sage,et al.  Development of UV-induced squamous cell carcinomas is suppressed in the absence of SPARC. , 2004, The Journal of investigative dermatology.

[12]  J. Rutka,et al.  International Hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactions. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[13]  E Helene Sage,et al.  Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis. , 2004, Molecular cancer research : MCR.

[14]  J. Kearney,et al.  Development and selection of marginal zone B cells , 2004, Immunological reviews.

[15]  M. Colombo,et al.  Leukocyte, Rather than Tumor-produced SPARC, Determines Stroma and Collagen Type IV Deposition in Mammary Carcinoma , 2003, The Journal of experimental medicine.

[16]  I. Kalajzic,et al.  Osteonectin-null mutation compromises osteoblast formation, maturation, and survival. , 2003, Endocrinology.

[17]  E. Sage,et al.  SPARC-null mice exhibit increased adiposity without significant differences in overall body weight , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Brekken,et al.  Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM. , 2003, The Journal of clinical investigation.

[19]  O. Volpert,et al.  SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. , 2002, Cancer research.

[20]  N. Lemke,et al.  Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. , 2002, Cancer research.

[21]  M. Reed,et al.  SPARC-null Mice Exhibit Accelerated Cutaneous Wound Closure , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[22]  R. Berkowitz,et al.  SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells. , 2001, The American journal of pathology.

[23]  S. Pillai,et al.  The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. , 2001, Immunity.

[24]  E. Sage,et al.  SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. , 2001, The Journal of clinical investigation.

[25]  R. Savani,et al.  Bleomycin-induced pulmonary injury in mice deficient in SPARC. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[26]  J. Schlessinger,et al.  Absence of marginal zone B cells in Pyk-2–deficient mice defines their role in the humoral response , 2000, Nature Immunology.

[27]  T. Mikkelsen,et al.  Increased SPARC expression promotes U87 glioblastoma invasion in vitro , 1999, International Journal of Developmental Neuroscience.

[28]  E. Sage,et al.  SPARC deficiency leads to early-onset cataractogenesis. , 1998, Investigative ophthalmology & visual science.

[29]  T. Mikkelsen,et al.  SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. , 1998, Journal of neuropathology and experimental neurology.

[30]  J. Sanes,et al.  Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age‐onset cataract formation and disruption of the lens , 1998, The EMBO journal.

[31]  O. Podhajcer,et al.  Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells , 1997, Nature Medicine.

[32]  O. Podhajcer,et al.  The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma. , 1997, The Journal of investigative dermatology.

[33]  K. Oritani,et al.  Identification of stromal cell products that interact with pre-B cells , 1996, The Journal of cell biology.

[34]  R. Berkowitz,et al.  SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells. , 1996, Oncogene.

[35]  M. Iruela-Arispe,et al.  Distribution of the calcium-binding protein SPARC in tissues of embryonic and adult mice. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[36]  N. Harris,et al.  A simple method for the isolation of murine peripheral blood lymphocytes. , 1978, Journal of immunological methods.

[37]  S. Pillai,et al.  Marginal zone B cells. , 2005, Annual review of immunology.